Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
19%

OVERLAP
BY WEIGHT
13

# OF OVERLAPPING
HOLDINGS
IBRN
73
HOLDINGS
26%
ALSO IN SBIO
SBIO
75
HOLDINGS
17%
ALSO IN IBRN
SECTOR DRIFT (IBRN minus SBIO)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IBRN
Weight
in SBIO
Overlap
ALKERMES PLC 5.1% 4.5% 4.5%
DIANTHUS THERAPEUTICS INC 3.5% 2.6% 2.6%
ACADIA PHARMACEUTICALS INC 3.4% 2.4% 2.4%
EDGEWISE THERAPEUTICS, INC. 2.7% 2.3% 2.3%
DENALI THERAPEUTICS INC. 3.1% 2.1% 2.1%
IBRN Overweight Relative to SBIO
AXSOME THERAPEUTICS, INC. 5.0%
ARROWHEAD PHARMACEUTICALS, INC. 4.5%
NEUROCRINE BIOSCIENCES INC 4.3%
PTC THERAPEUTICS INC 4.1%
ARGENX SE ADR 4.0%
SCHOLAR ROCK HOLDING CORP. 3.8%
BIOGEN IDEC INC 3.7%
CATALYST PHARMACEUTICAL PART 3.5%
SUPERNUS PHARMACEUTICALS INC 2.6%
DYNE THERAPEUTICS INC 2.5%
IBRN Underweight Relative to SBIO
KYMERA THERAPEUTICS, INC. -4.2%
CELCUITY INC. -3.9%
MIRUM PHARMACEUTICALS, INC. -3.9%
SPYRE THERAPEUTICS INC -3.7%
CG ONCOLOGY, INC. -3.3%
APOGEE THERAPEUTICS, INC. -2.9%
TRAVERE THERAPEUTICS, INC. -2.8%
NEWAMSTERDAM PHARMA CO NV -2.5%
VIKING THERAPEUTICS, INC. -2.4%
CRINETICS PHARMACEUTICALS INC -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY